C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/02/2004	US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors
12/02/2004	US20040241157 Collagenolytic activity; glycosaminoglycans; drug screening; kits; for treatment of osteoporosis, skin aging, Paget's disease, and rheumatoid arthritis
12/02/2004	US20040241156 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder
12/02/2004	US20040241096 Detect enzyme activity in sample; incubation target tissue; detect amplification in sample
12/02/2004	US20040238379 Electronically detecting hybridization of probe and target; eliminates labeling
12/02/2004	US20040238360 Potentiometric sensor device
12/02/2004	US20040238359 Biosensor
12/02/2004	US20040238358 Biosensor
12/02/2004	US20040238357 Sensor system
12/02/2004	US20040238267 Diaphragm structure of light sound converter
12/02/2004	DE10351065A1 Sondenberechnung Probe calculation
12/02/2004	DE10331107B3 Detecting cytosine methylation in DNA, useful e.g. for diagnosis of cancer, comprises using a cytidine deaminase selective for unmethylated residues, and detecting presence or amount of deaminated residues
12/02/2004	DE10325098B3 Verfahren zur SNP-Analyse auf Biochips mit Oligonukleotid-Arealen A method for SNP analysis on biochips with oligonucleotide areas
12/02/2004	DE10320899A1 Apparatus with sensors for amperometric- or potentiometric testing of pharmaceutical sites of action and active substances, includes membrane biosensor region
12/02/2004	DE10320898A1 Biokompatible Sensorelektrodenanordnung und Verfahren zu deren Herstellung Biocompatible sensor electrode arrangement, and processes for their preparation
12/02/2004	DE10320312A1 Substrat als Träger von Ligaten Substrate as a carrier of ligates
12/02/2004	DE10245145B4 Verfahren zum Nachweis von SNPs auf polydimensionalen Microarrays A method for the detection of SNPs on microarrays polydimensional
12/02/2004	CA2690035A1 Use of a mouse to screen for an inhibitor of interleukin 18 production in keratinocytes
12/02/2004	CA2531337A1 Methods and kits for quantifying metabolites or analytes
12/02/2004	CA2526985A1 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004	CA2526790A1 Method for screening inhibitors of the gamma-secretase
12/02/2004	CA2526697A1 Use of a polypeptide
12/02/2004	CA2526661A1 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
12/02/2004	CA2526650A1 A pair of probes for analyzing protein-protein interaction and a method for analyzing protein-protein interaction using the same
12/02/2004	CA2526585A1 Permselective structurally robust membrane material
12/02/2004	CA2526476A1 Mass-based toxin assay and substrates therefor
12/02/2004	CA2526409A1 Nucleic acid processing methods, kits and devices
12/02/2004	CA2526403A1 New enterovirus, vaccines, medicaments and diagnostic kits
12/02/2004	CA2526173A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
12/02/2004	CA2526127A1 Method of analyzing physiological function of target substance
12/02/2004	CA2526036A1 Methods and compositions for diagnosing and treating disorders involving angiogenesis
12/02/2004	CA2525698A1 A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein
12/02/2004	CA2525332A1 Systems and methods for fluorescence detection with a movable detection module
12/02/2004	CA2525012A1 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
12/02/2004	CA2524675A1 Markers for lxr activation
12/02/2004	CA2524130A1 Ranbp2 as modifier of the pten/igf pathway and methods of use
12/02/2004	CA2523786A1 A .delta.-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
12/01/2004	EP1482439A2 Visualization method of RNA Pseudoknot structures
12/01/2004	EP1482308A1 Method of evaluating qualities of food or drink and indicator therefor
12/01/2004	EP1482307A1 Biosensor
12/01/2004	EP1482059A1 Comparative genomic hybridization assays using immobilized oligonucleotide targets
12/01/2004	EP1482058A1 Method of testing wheat
12/01/2004	EP1482057A2 Quantitative determination method of mannose and reagent therefor
12/01/2004	EP1482056A2 Biosensor
12/01/2004	EP1482053A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/01/2004	EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
12/01/2004	EP1482036A2 A method for increasing the concentration of a nucleic acid molecule
12/01/2004	EP1482034A1 Novel oxidase
12/01/2004	EP1481990A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481987A1 Method for screening inhibitors of the gamma-secretase
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481371A1 Method for separating a group of cells which are contained in an image sample into individual cells
12/01/2004	EP1481251A2 Estrogen receptor interaction with a transcription factor
12/01/2004	EP1481250A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/01/2004	EP1481248A2 Methods for absolute cell counting
12/01/2004	EP1481098A1 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/01/2004	EP1481097A1 Rapid analysis of variations in a genome
12/01/2004	EP1481096A1 Surface modification, linker attachment, and polymerization methods
12/01/2004	EP1481095A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
12/01/2004	EP1481094A2 Increasing the sensitivity and specificity of nucleic acid chip hybridization tests
12/01/2004	EP1481093A2 MODULATION OF TYPE II&bgr; PHOSPHOINOSITIDE PHOSPHATE KINASE
12/01/2004	EP1481092A2 Methods for detection of genetic disorders
12/01/2004	EP1481091A2 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
12/01/2004	EP1481090A1 Methods and reagents for detecting target binding by nucleic acid ligands
12/01/2004	EP1481089A2 Methods based on hormone dependency of primary cancer cells
12/01/2004	EP1481088A2 Polynomial amplification of nucleic acids
12/01/2004	EP1481086A2 HIGH−SENSITIVITY REAL−TIME POLYMERASE CHAIN REACTION FOR DETECTION OF NUCLEIC ACIDS
12/01/2004	EP1481084A2 The use of ribozymes in the detection of adventitious agents
12/01/2004	EP1481083A2 NUCLEIC ACID PROBES, THEIR SYNTHESIS AND USE
12/01/2004	EP1481080A2 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics
12/01/2004	EP1481076A2 Multiplex nucleic acid reactions
12/01/2004	EP1481066A2 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
12/01/2004	EP1481065A2 Method for detection of leptin receptor ligands
12/01/2004	EP1481059A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1480772A2 Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems
12/01/2004	EP1480748A1 Holding tray having through-hole wells
12/01/2004	EP1480668A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization,or both, in humans
12/01/2004	EP1480656A1 Hyaluronic acid mediated adenoviral transduction
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480597A2 Screening, diagnostic and therapeutic methods relating to riz
12/01/2004	EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/01/2004	EP1480520A2 Human fetal bladder-derived epithelial cells
12/01/2004	EP1439861A4 Methods and kits for use in selecting approaches to treating cancer
12/01/2004	EP1421200A4 Fluorescent multiplex hpv pcr assays using multiple fluorophores
12/01/2004	EP1406765A4 Droplet dispensing system
12/01/2004	EP1206575A4 Transcription-free selex
12/01/2004	EP1196755B1 Genetic assay system
12/01/2004	EP1196539A4 Substrates for nucleic acid immobilization onto solid supports
12/01/2004	EP1196198A4 Method of screening for drugs useful in treating alzheimer's disease
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP1171630B1 Biological fluid assay methods
12/01/2004	EP1088097A4 Comparative phenotype analysis
12/01/2004	EP1073771B1 New method for the selection of clones of an expression library involving rearraying
12/01/2004	EP1029074B1 Differential staining of bacteria using fluorescence
12/01/2004	EP0970245B1 Method for the identification of genetic subtypes
12/01/2004	EP0906448A4 Methods for the diagnosis and prognosis of cancer
12/01/2004	EP0820524B1 Detecting dna sequence variations
12/01/2004	EP0720650B1 Human metabotropic glutamate receptor subtype hmglur7 and related dna compounds

1 ... 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 ... 3003